The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 11 of the 72 sources its claims cite were checked for support.
Abstract
Background: Antidepressant withdrawal is experienced by about half of people who try to reduce or come off their medication. It can be a debilitating, long lasting process. Many clinicians misdiagnose or minimise symptoms, inadvertently prolonging suffering. Most are unable to help patients safely taper off. There has been little research into the peer support communities that are playing an increasingly important role in helping people withdraw from psychiatric medications. Methods: To illustrate the growth and activities of Facebook withdrawal groups, we examined 13 such groups. All were raising awareness of, and supporting individuals tapering off, antidepressants and were followed for 13 months. A further three groups were added for the last 5 months of the study. Results: In June 2020, the groups had a total membership of 67,125, of which, 60,261 were in private groups. The increase in membership for the 13 groups over the study period was 28.4%. One group was examined in greater detail. Group membership was 82.5% female, as were 80% of the Administrators and Moderators, all of whom are lay volunteers. Membership was international but dominated (51.2%) by the United States (US). The most common reason for seeking out this group was failed clinician-led tapers. Discussion: The results are discussed in the context of research on the prevalence, duration and severity of antidepressant withdrawal. We question why so many patients seek help in peer-led Facebook groups, rather than relying on the clinicians that prescribed the medications. The withdrawal experiences of tens of thousands of people remain hidden in these groups where they receive support to taper when healthcare services should be responsible. Further research should focus on the methods of support and tapering protocols used in these groups to enable improved, more informed support by clinicians. Support from Governments and healthcare agencies is also needed, internationally, to address this issue.
Overview
CoChat Summary
TL;DR
This study maps 16 Facebook groups supporting antidepressant withdrawal, finding 67,125 members in June 2020 and rapid growth, with most members seeking help after failed clinician-led tapers. It argues these peer-led groups are filling a gap left by health services that often misdiagnose or inadequately manage withdrawal.
Key findings
- Across 16 groups, total membership was 67,125 on 10 June 2020; 60,261 were in private groups. The 13 groups followed for 13 months grew 28.4%, while all 16 grew 7.2% between first and last sampling dates.
- In detailed Group 1 (venlafaxine), membership was 82.5% female; 80% of Administrators and Moderators were female; 51.2% of members were from the US. Failed clinician-led tapers were the most common reason for joining, estimated at 80–90%.
- Group 1 recorded 7,127 posts (daily mean 20 ± 6) and 103,670 comments (285 ± 91) in the year to 25 January 2020, with mean daily active members 1428 ± 212; 39% of applicants were declined in that year.
- Duloxetine had the most group activity: five duloxetine groups had 34,852 members (three private: 30,412); sertraline was second (9,649 in two private groups) and venlafaxine third (8,290 in two private groups).
Methods
- Searched Facebook for public/private groups using keywords such as antidepressants, withdrawal and support; included only groups with “withdrawal” in the name or description. Sampled 16 groups (13 private, 3 public); membership was observed on five dates for 13 groups and three dates for 3 groups; admin/mod and group age data were collected on 25 January 2020.
- Detailed Group 1 used Facebook Group Insights for 25 January 2019–25 January 2020 plus owner records since 2013; extracted membership growth, posts/comments, age/sex, location and admin/mod activity, omitting personal identifiers. Ethics approval was from the University of East London (ETH1920-0260).
- Analysis was descriptive: membership totals and growth rates, plus Pearson correlations between group size and growth and between country population and members.
Limitations
- Stated: the data cannot estimate the incidence or severity of antidepressant withdrawal in the general patient population, nor the proportion of patients on antidepressants who find these groups; admin/mod numbers were observed once and may have changed; successful taperers may remain and boost membership; double counting across groups is possible.
- Evident from the text: the sample is not exhaustive and likely underestimates total Facebook withdrawal support; selection required “withdrawal” in the group name/description and relied on Facebook search; only one group was examined in detail; gender data were incomplete because generic admin/mod accounts could not be classified.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
5 Valid · 5 Not valid · 31 Not checked · 108 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“We believe this is the first study to examine the role of Facebook groups in supporting people discontinue antidepressants or indeed, any psychiatric medication.”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Discussion > Group membership numbers, growth rates and reasons for seeking peer support
What the sources say
- Disputedcites [33] Mota Pereira J Facebook enhances antidepressant pharmacotherapy effects. ScientificWorldJournal 2014; 2014: 892048. 24574930 PMC3916106 sourceExperimental — accuracy not yet measured
The Study Protocol (§2.4; page not provided) says all patients maintained their usual pharmacotherapy throughout the study. The Discussion (§4) likewise says they continued taking medication. This study examined Facebook use alongside treatment, not Facebook groups supporting medication discontinuation. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [34] Mehta N Atreja A. Online social support networks. Int Rev Psychiatry 2015; 27: 118– 123. 25800079 source
- Could not verifycites [35] Naslund J Aschbrenner K Marsch L, et al The future of mental health care: peer-to-peer support and social media. Epidemiol Psychiatr Sci 2016; 25: 113– 122. 26744309 PMC4830464 sourceExperimental — accuracy not yet measured
The section on access to interventions discusses online peer support for serious mental illness, but not Facebook groups supporting antidepressant or other psychiatric-medication discontinuation. Searches for Facebook groups and medication discontinuation found no passage establishing the claimed first-study status. (LLM, conf=0.75)
- Disputedcites [36] Naslund JA Aschbrenner KA Marsch LA, et al Facebook for supporting a lifestyle intervention for people with major depressive disorder, bipolar disorder, and schizophrenia: an exploratory study. Psychiatr Q 2018; 89: 81– 94. 28470468 PMC5758428 sourceExperimental — accuracy not yet measured
The Abstract Methods and Introduction describe a Facebook group supporting weight loss and physical activity among people with serious mental illness. The paper does not examine discontinuing antidepressants or other psychiatric medication; it identifies a different purpose for the study. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Despite this evidence, many doctors and psychiatrists are reluctant to accept patients are presenting with withdrawal from the medications.19,24–26”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Introduction > Antidepressant withdrawal
What the sources say
- Supportedcites [19] Cosci F Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom 2020; 89: 283– 306. 32259826 source
The Conclusions (p. 18) explicitly describe reluctance to accept that psychoactive drugs can cause withdrawal and warn that patients presenting with withdrawal syndromes risk misdiagnosis. The Clinical Implications section (p. 17) also says clinicians find withdrawal syndromes challenging to recognize. (LLM, conf=0.89)
- Not checked yetcites [24] Davies J Pauli R Montagu L. Antidepressant withdrawal: a survey of patients’ experience by the all-party parliamentary group for prescribed drug dependence, http://prescribeddrug.org/wp-content/uploads/2018/09/APPG-PDD-Antidepressant-Withdrawal-Patient-Survey.pdf (accessed September 2018).
- Not checked yetcites [25] Davies J Pauli R Montagu L. A survey of antidepressant withdrawal reactions and their management in primary care. All Party Parliamentary Group for Prescribed Drug Dependence, 2018.
- Not checked yetcites [26] Hengartner M Plöderl M. False beliefs in academic psychiatry: the case of antidepressant drugs. Ethical Hum Psychol Psychiatry 2018; 20: 6– 17. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The symptoms are often far in excess, in terms of both quantity and intensity, of the problems for which the drugs were initially prescribed.10,20”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Introduction > Antidepressant withdrawal
What the sources say
- Partly supportedcites [10] Davies J Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence- based? Addict Behav 2019; 97: 111– 121. 30292574 sourceExperimental — accuracy not yet measured
The Introduction lists many withdrawal symptoms, and §3.3 (Severity) reports that 43–51% of respondents who experienced withdrawal selected the most severe rating offered. These passages support the breadth and potential severity of withdrawal, but the paper does not establish that symptoms are often greater in number or intensity than the problems for which the drugs were initially prescribed. Page numbers were not provided in our copy. (LLM, conf=0.85)
- Partly supportedcites [20] Horowitz M Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019; 6: 538– 546. 30850328 sourceExperimental — accuracy not yet measured
The SSRI withdrawal discussion (page unavailable in our copy) describes a wide variety of symptoms, some distinct from the original illness. It also reports that nearly half of participants who experienced withdrawal selected the most extreme severity rating. It does not establish that withdrawal symptoms are often far greater in number and intensity than the problems for which antidepressants were prescribed. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Apart from the Horowitz–Taylor tapering method,20 and the work of Peter Groot and Jim van Os in the Netherlands,54–56 there seem to be no good studies on how to safely taper patients off these medications.”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Discussion > Why do these groups exist and what is their context in the antidepressant withdrawal issue?
What the sources say
- Supportedcites [20] Horowitz M Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019; 6: 538– 546. 30850328 source
Citation 20 is attached to the Horowitz–Taylor tapering method, not to the separate Groot–van Os work. In “Future directions for research,” the paper identifies its own proposal as a pharmacologically informed guide for SSRI withdrawal and says its validity still needs confirmation in randomised controlled trials. (LLM, conf=0.92)
- Not checked yetcites [54] Groot PC van Os J Antidepressant tapering strips to help people come off medication more safely. Psychosis 2018; 10: 142– 145. source
- Supportedcites [55] Groot PC van Os J How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. Ther Adv Psychopharmacol 2020; 10: 2045125320932452. PMC7357127 32699604 source
The citation identifies the work of Peter Groot and Jim van Os as an exception. In “Experiences with the use of tapering strips,” they describe their observational study of 1,194 patients using tapering medication and report that 70% tapered their antidepressant completely. (LLM, conf=0.90)
- Supportedcites [56] Groot PC van Os J The outcome of antidepressant drug discontinuation with tapering strips after 1-5 years. Ther Adv Psychopharmacol 2020; 10: 2045125320954609. PMC7476339 32953040 source
The citation identifies the work of Groot and van Os as research on tapering antidepressants. In Discussion > Findings, the paper reports that 68% of participants remained off medication 1–5 years after using taperingstrips. The claim that there are no other good studies is the citing authors’ assessment, not a finding attributed to this source. (LLM, conf=0.91)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Research suggests those who are fully supported during drug withdrawal, either by peers (via groups such as those followed in this study), healthcare experts or support staff have a more successful outcome.8,13,48”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Discussion > Why do these groups exist and what is their context in the antidepressant withdrawal issue?
What the sources say
- Not checked yetcites [8] Fixsen AM Ridge D. Stories of hell and healing: internet users’ construction of benzodiazepine distress and withdrawal. Qual Health Res 2017; 27: 2030– 2041. 28891380 source
- Partly supportedcites [13] Ostrow L Jessell L Hurd M, et al Discontinuing psychiatric medications: a survey of long-term users. Psychiatr Serv 2017; 68: 1232– 1238. 28712356 sourceExperimental — accuracy not yet measured
Our copy supports only the 'support is experienced as helpful' half of the claim: the Self-care/Social support results (p. ~4) report that 42% found friends and others who had discontinued helpful, 41% internet support groups, 39% family, and 76% self-education, and the DISCUSSION says respondents 'found these sources of support particularly helpful' and that resources employing them 'may be especially promising.' What the source does not support is the outcome association: it reports no analysis linking being 'fully supported' during withdrawal to a more successful outcome — the only outcome figures are that 54% met their discontinuation goal and 82% of those were satisfied, with satisfaction not tied to support level. Moreover, the 'healthcare experts' component is undercut rather than confirmed: only 45% of those working with a prescriber rated the prescriber helpful, and the DISCUSSION states 'most did not indicate that providers were helpful during the ensuing experience of discontinuation.' (LLM, conf=0.72)
- Not checked yetcites [48] Guy A Frederick B Davies J, et al The role of the therapist in assisting withdrawal from psychiatric drugs: what do we know about what is helpful? In: Guy A. Davies J. Rizq R. (eds) Guidance for psychological therapists: enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs. London: APPG for Prescribed Drug Dependence, 2019.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims
Create a free account to see all 149 claims and to verify the 61 references still open.
- Probably not a substantial claim. 70
- It may state two separate claims as one. 33
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the absence of RCTs, tapering guidance could be informed by other types of evidence such as non-randomised and retrospective studies of tapering strips,17,18 pharmacologically rational theory on withdrawal symptoms and dose-reduction regimens,12,49 patients’ experiences of undergoing withdrawal, 50 and expert knowledge, 51 which could be synthesised for that purpose.”
From Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review (2022) · cites this paper as [50]
In the citing paper
“withdrawal and inability to discontinue antidepressant medication represent a significant public health problem,5”
From Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Where country membership was greater than 20 (Figure 5), 94.5% of the total group membership was accounted for by five countries. The US was by the far the most common country of origin (51.2% of members on 29 January 2020). The UK had 17.3%, Canada 9.2%, Australia 6.8% and New Zealand 3.2%.”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Results > Detailed examination of Group 1: effexor (venlafaxine) tapering, discontinuation syndrome and protracted withdrawal
Reported 94.5 · recomputed 87.7
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Results > Detailed examination of Group 1: effexor (venlafaxine) tapering, discontinuation syndrome and protracted withdrawal
“Where country membership was greater than 20 (Figure 5)”
§ The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? > Results > Detailed examination of Group 1: effexor (venlafaxine) tapering, discontinuation syndrome and protracted withdrawal
“Figure: Figure 5. Percentage of male and female members in Group 1 by age range (years) and sex in June 2020; n = 6162.”
Citations
Cites
The future of mental health care: peer-to-peer support and social media
Naslund, J. A., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001067 · Cited by 1,180
Sex differences in pharmacokinetics predict adverse drug reactions in women
Zucker, I., & Prendergast, B. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00308-5 · Cited by 777
Sharing Health Data for Better Outcomes on PatientsLikeMe
Wicks, P., Massagli, M., Frost, J., Brownstein, C., Okun, S., Vaughan, T., Bradley, R., & Heywood, J. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1549 · Cited by 603
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387 · cited 1×
“Antidepressant withdrawal is characterised by many and varied symptoms that appear days, weeks or months after stopping a medication.(10,17,18) The symptoms are often far in excess, in terms of both quantity and intensity, of the problems for which the drugs were initially prescribed.”
BackgroundSelf-citationAntidepressant Use Among Persons Aged 12 and Over:United States,2011-2014.
Pratt, L. A., Brody, D. J., & Gu, Q. (2017) · PubMed · Cited by 355
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280 · cited 1×
“It is clear however, the longer patients take these medications, the more severe the withdrawal symptoms they may experience 42,44,49 and the more difficult and protracted their withdrawal experience may be.(20) Hence, far greater investment is required in terms of”
BackgroundGiustini, D. M., Ali, S. M., Fraser, M., & Boulos, M. N. K. (2018) · Online Journal of Public Health Informatics · doi:10.5210/ojphi.v10i2.8270 · Cited by 271 · cited 1×
“A systematic review of data on the use of social media for public health topics in general concluded that qualitative benefits can be derived in terms of learning and education for both patients and physicians.(4) The authors also concluded there are both negatives and positives from this form of learning and support.”
BackgroundAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Research works printed but not linked: 4
- Witt-Doerring J Shorter D Kosten M. Online communities for drug withdrawal: what can we learn? Psychiatr Times 2018; 35: 4.
- Davies J Pauli R Montagu L. A survey of antidepressant withdrawal reactions and their management in primary care. All Party Parliamentary Group for Prescribed Drug Dependence, 2018.
- Horowitz M. Antidepressant withdrawal syndrome and its management. London: Royal College of Psychiatrists, 2019.
- Young A Currie A. Physicians’ knowledge of antidepressant withdrawal effects: a survey. J Clin Psychiatry 1997; 58: 28– 30. 9219491
Cited by
Prajapati, R., & Liebling, H. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-00993-x · Cited by 127
(2022) · doi:10.1192/bja.2021.62 · Cited by 73
“Misdiagnosis of withdrawal effects as relapse by their doctors was a common motivation cited by 67 000 people who sought peer advice on social media sites on how to stop antidepressants (White 2021).”
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Sørensen, A., Juhl Jørgensen, K., & Munkholm, K. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211067656 · Cited by 52
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Groot, P. C., & van Os, J. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211039327 · Cited by 38
“Variables collected were: (1) age (in years), (2) sex, (3) type of medication and duration of use prior to tapering, (4) number of attempts to stop medication before using tapering strips, (5) severity of withdrawal symptoms during previous discontinuation attempts without tapering strips on a 1–7 Likert scale (‘Did y…”
Background
Metadata
- Authors
- White, E., Read, J., & Julo, S.
- Affiliations
- Independent Researcher, Knapp House, 66 North Street, Pewsey, SN95NX UK
- University of East London (GB)
- Kansas City, MO, USA
- Corresponding author
- Read, John
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2021-01
- Volume
- 11
- Pages
- 2045125320981174-2045125320981174
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC7816538
- OpenAlex
- W3112695252
- Semantic Scholar
- e34cb0f9246acca1a7eb668b440d96eeb7a1097e
- Cited by
- 63
- References
- 52
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 9
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UEL Research Repository (University of East London) (submittedVersion)
- Topics
- Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
- Social Sciences › Health › Social Media in Health Education
- Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
- Keywords
- antidepressant discontinuation, Facebook groups, social media, peer support, medication tapering, online communities, lay volunteers, patient awareness, mental health services
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? https://app.cochat.ai/papers/10.1177/2045125320981174
- The paper
- White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320981174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.